Jeffrey Lawrence

1.4k total citations
24 papers, 1.1k citations indexed

About

Jeffrey Lawrence is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Jeffrey Lawrence has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Jeffrey Lawrence's work include Peroxisome Proliferator-Activated Receptors (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Jeffrey Lawrence is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Jeffrey Lawrence collaborates with scholars based in United States, United Kingdom and Switzerland. Jeffrey Lawrence's co-authors include W. van Walbeek, Peter Scott, Thomas C. Rowe, Volkmar Weissig, Peter Scott, Patrick I. Eacho, David J. Kroll, John G. DeLuca, J. Harwig and Shiying Chen and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Advanced Drug Delivery Reviews.

In The Last Decade

Jeffrey Lawrence

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey Lawrence United States 15 601 268 139 130 125 24 1.1k
Bill E. Cham Australia 17 659 1.1× 186 0.7× 148 1.1× 68 0.5× 79 0.6× 64 1.5k
Yasuyuki Ohtake Japan 25 1.3k 2.1× 284 1.1× 182 1.3× 83 0.6× 140 1.1× 48 2.3k
Koji Furuno Japan 16 388 0.6× 129 0.5× 125 0.9× 74 0.6× 162 1.3× 35 1.0k
T. P. Krishnakantha India 17 517 0.9× 211 0.8× 123 0.9× 202 1.6× 33 0.3× 35 1.2k
Krishna B. Sainis India 28 714 1.2× 291 1.1× 147 1.1× 226 1.7× 42 0.3× 65 2.1k
Lisa J. Wilcox United States 18 716 1.2× 143 0.5× 99 0.7× 48 0.4× 175 1.4× 22 1.4k
Ying Zeng China 26 1.1k 1.9× 364 1.4× 140 1.0× 173 1.3× 119 1.0× 95 1.9k
Silvia Franceschelli Italy 19 760 1.3× 170 0.6× 111 0.8× 64 0.5× 158 1.3× 43 1.2k
Masayuki Nakanishi Japan 19 868 1.4× 192 0.7× 72 0.5× 70 0.5× 269 2.2× 66 1.5k
Richard Isbrucker Canada 20 492 0.8× 121 0.5× 189 1.4× 379 2.9× 64 0.5× 42 1.6k

Countries citing papers authored by Jeffrey Lawrence

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Lawrence more than expected).

Fields of papers citing papers by Jeffrey Lawrence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Lawrence. The network helps show where Jeffrey Lawrence may publish in the future.

Co-authorship network of co-authors of Jeffrey Lawrence

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Lawrence. A scholar is included among the top collaborators of Jeffrey Lawrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Lawrence. Jeffrey Lawrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glaab, Warren E., Daniel Holder, Yudong D. He, et al.. (2021). Universal Toxicity Gene Signatures for Early Identification of Drug-Induced Tissue Injuries in Rats. Toxicological Sciences. 181(2). 148–159. 16 indexed citations
2.
Magi‐Galluzzi, Cristina, Sudhir Isharwal, Sara M. Falzarano, et al.. (2018). The 17-Gene Genomic Prostate Score Assay Predicts Outcome After Radical Prostatectomy Independent of PTEN Status. Urology. 121. 132–138. 6 indexed citations
3.
Eeden, Stephen Van Den, Nan Zhang, Jun Shan, et al.. (2017). MP20-05 A DIAGNOSTIC BIOPSY-BASED GENOMIC PROSTATE SCORE AS AN INDEPENDENT PREDICTOR OF PROSTATE CANCER DEATH AND METASTASIS IN MEN WITH LOCALIZED PROSTATE CANCER. The Journal of Urology. 197(4S). 2 indexed citations
4.
Berse, Brygida, Atreya Dash, Michael K. Brawer, et al.. (2016). Caring for Patients With Prostate Cancer Who Are BRCA Positive.. PubMed. 33(Suppl 1). 46S–51S. 1 indexed citations
5.
Leapman, Michael, Antonio C. Westphalen, Niloufar Ameli, et al.. (2015). MP53-18 ASSOCIATION BETWEEN A 17-GENE GENOMIC PROSTATE SCORE AND MULTI-PARAMETRIC PROSTATE MRI IN MEN WITH LOW AND INTERMEDIATE RISK PROSTATE CANCER (PCA). The Journal of Urology. 193(4S). 1 indexed citations
6.
Lafleur, Marc A., James Stevens, & Jeffrey Lawrence. (2013). Xenobiotic Perturbation of ER Stress and the Unfolded Protein Response. Toxicologic Pathology. 41(2). 235–262. 27 indexed citations
7.
Thompson, Alastair M., Andrea Johnson, Philip Quinlan, et al.. (2010). Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy. Breast Cancer Research and Treatment. 125(1). 279–287. 71 indexed citations
8.
Figueroa, David J., et al.. (2008). Phospholipidosis Assay in HepG2 Cells and Rat or Rhesus Hepatocytes Using Phospholipid Probe NBD-PE. Assay and Drug Development Technologies. 6(3). 407–419. 31 indexed citations
9.
Meneses‐Lorente, Georgina, Paul C. Guest, Jeffrey Lawrence, et al.. (2004). A Proteomic Investigation of Drug-Induced Steatosis in Rat Liver. Chemical Research in Toxicology. 17(5). 605–612. 39 indexed citations
10.
Lawrence, Jeffrey, et al.. (2001). Dexamethasone Selectively Inhibits WY14,643-Induced Cell Proliferation and Not Peroxisome Proliferation in Mice. Toxicology and Applied Pharmacology. 170(2). 113–123. 12 indexed citations
11.
Rowe, Thomas C., Volkmar Weissig, & Jeffrey Lawrence. (2001). Mitochondrial DNA metabolism targeting drugs. Advanced Drug Delivery Reviews. 49(1-2). 175–187. 38 indexed citations
12.
Lawrence, Jeffrey, Ying Li, Shiying Chen, et al.. (2001). Differential Gene Regulation in Human Versus Rodent Hepatocytes by Peroxisome Proliferator-activated Receptor (PPAR) α. Journal of Biological Chemistry. 276(34). 31521–31527. 159 indexed citations
13.
Lawrence, Jeffrey. (2001). Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation. Carcinogenesis. 22(3). 381–386. 30 indexed citations
14.
Lawrence, Jeffrey, David J. Kroll, & Patrick I. Eacho. (2000). Ligand-dependent interaction of hepatic fatty acid-binding protein with the nucleus. Journal of Lipid Research. 41(9). 1390–1401. 73 indexed citations
15.
Lawrence, Jeffrey, et al.. (1996). Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells.. Molecular Pharmacology. 50(5). 1178–1188. 93 indexed citations
16.
Eacho, Patrick I., Patricia Foxworthy, Jeffrey Lawrence, David K. Herron, & Daniel J. Noonan. (1996). Common Structural Requirements for Peroxisome Proliferation by Tetrazole and Carboxylic Acid‐Containing Compounds. Annals of the New York Academy of Sciences. 804(1). 387–402. 4 indexed citations
17.
Lawrence, Jeffrey, et al.. (1995). Nafenopin-induced peroxisome proliferation in vitamin A deficient rats. Biochemical Pharmacology. 49(7). 915–919. 6 indexed citations
18.
Lawrence, Jeffrey, Sandra J. Darkin‐Rattray, Fan Xie, Allen H. Neims, & Thomas C. Rowe. (1993). 4‐Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells. Journal of Cellular Biochemistry. 51(2). 165–174. 73 indexed citations
19.
Scott, Peter, Jeffrey Lawrence, & W. van Walbeek. (1970). Detection of Mycotoxins by Thin-Layer Chromatography: Application to Screening of Fungal Extracts. Applied Microbiology. 20(5). 839–842. 217 indexed citations
20.
Walbeek, W. van, Peter Scott, J. Harwig, & Jeffrey Lawrence. (1969). Penicillium viridicatum Westling: a new source of ochratoxin A. Canadian Journal of Microbiology. 15(11). 1281–1285. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bill E. Cham Breakdown of academic impact, for papers by Yasuyuki Ohtake Breakdown of academic impact, for papers by Koji Furuno Breakdown of academic impact, for papers by T. P. Krishnakantha Breakdown of academic impact, for papers by Krishna B. Sainis Breakdown of academic impact, for papers by Lisa J. Wilcox Breakdown of academic impact, for papers by Ying Zeng Breakdown of academic impact, for papers by Silvia Franceschelli Breakdown of academic impact, for papers by Masayuki Nakanishi Breakdown of academic impact, for papers by Richard Isbrucker
Rankless by CCL
2026